Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 446, 358-359 (22 March 2007) | doi:10.1038/446358b; Published online 21 March 2007
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Academic Neuropathologist
- University Hospitals Case Medical Center
- Cleveland, Ohio, USA
Senior Medical Writer
- Cactus Global
- Mumbai 400053 India
Experts call for active surveillance of drug safety
Meredith Wadman
Earlier this month, the US Food and Drug Administration (FDA) cautioned Americans that two classes of drugs in widespread use have serious and sometimes life-threatening side effects that warrant new label warnings.On 9 March, the agency announced that three erythropoietin-type drugs for treating anaemia increase the risk of death, blood clots, strokes and heart attacks, and accelerate the growth of some cancers.
To read this story in full you will need to login or make a payment (see right).
